Back to Posters

Multi-gene Panel Testing for Prostate Cancer: What Have We Learned So Far?

Date:
Friday, Sep 15, 2017 1:15pm – 2:30pm
Conference:
NSGC 2017
Authors:
Carin Espenschied, Holly Laduca, Lauren Bowling, Michelle Jackson
  • Hereditary prostate cancer testing is underutilized especially when compared to hereditary breast cancer testing
  • HOXB13 was a new finding, identified in 17% of positive patients
  • 13% of positive patients did not meet NCCN genetic testing guidelines for BRCA1/2
Poster